CTX112
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for CTX112, covering 2025-11-14 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease [Phase 1, Phase 2]